Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism 5-HT2A receptor antagonists(Serotonin 2a (5-HT2a) receptor antagonists), mGluR2 positive allosteric modulator(Metabotropic glutamate receptor 2 positive allosteric modulator) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Sleep | Preclinical | BE | 11 Dec 2015 |